T he study of perioperative medicine outcomes using large databases, so-called big data, has emerged as a valuable approach that increasingly challenges longheld clinical beliefs and forces us to rethink mechanistic paradigms underlying postoperative morbidity. In this issue of Anesthesia & Analgesia, the Department of Outcomes Research at the Cleveland Clinic continues to build on their major contribution to the perioperative medicine big data portfolio by reporting the results of the largest study yet that focuses on the relationship between rheumatoid arthritis and perioperative outcomes. 1 The authors tested the primary hypothesis that rheumatoid arthritis is independently associated with increased postoperative cardiovascular complications. This hypothesis is highly plausible given the well-established literature in rheumatoid arthritis demonstrating an increased risk of atherosclerosis, coronary artery disease, and all-cause cardiovascular morbidity in the nonoperative setting. 2 Patients with rheumatoid arthritis have an increased risk of myocardial infarction that is equivalent to patients who have diabetes mellitus or those patients without rheumatoid arthritis who are 10 years older. 3 The underlying mechanisms are incompletely understood, particularly because the increased risk of cardiovascular disease in patients with rheumatoid arthritis precedes their diagnosis based on the American College of Rheumatology criteria. 4 This excess risk cannot be explained by conventional risk factors. 5 Mirroring the myocardial injury phenotype of perioperative patients more generally, 6 patients with rheumatoid arthritis rarely present with angina and have higher rates of unrecognized cardiovascular disease. 4 In the Cleveland Clinic's Department of Outcomes Research analysis, inpatient hospital data across 7 American states for 1 year were assessed; each patient with rheumatoid arthritis was propensity matched with a suitable control. Multivariable logistic regression was used to compare matched rheumatoid arthritis and control patients on risk of in-hospital cardiovascular complications. Approximately 1.2% of patients undergoing noncardiac surgery had a coded diagnosis of rheumatoid arthritis; of these, 1095 rheumatoid patients were propensity matched with 1006 control patients. Unexpectedly, patients with rheumatoid arthritis were not found to be at more risk of cardiovascular complications (odds ratio, 1.08; 95% confidence interval [CI], 0.96-1.21; P = 0.08), with a similar incidence of thromboembolic complications and mortality. These findings mirror those from the Veterans Affairs Surgical Quality Improvement Program (VASQIP), where patients with rheumatoid arthritis were more likely to require a return to the operating room yet had similar rates of VASQIP-defined postoperative infection, cardiovascular events, and mortality. 7 These findings were broadly similar to those of a systematic review and meta-analysis of 40 studies comparing complications after total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. 8 Although this systematic review is rather hampered by a lack of studies explicitly defining rheumatoid arthritis, and/or adjusting for covariates, patients with rheumatoid arthritis appeared to be at a higher risk of infection after total knee arthroplasty. This finding is consistent with the link between infectious complications and cardiovascular morbidity, as shown by the perioperative association between achieving adequate oxygen delivery and fewer postoperative hospital-acquired infections in the higher-risk surgical population. 9, 10 This observation was strengthened by an earlier need for revision of total knee arthroplasties in patients with rheumatoid arthritis. Avoiding revision procedures in patients with rheumatoid arthritis may be particularly important because they appear to be at an increased risk of prosthetic joint infection. 11, 12 Taken together these findings would appear to suggest that perioperative physicians may have unduly judged patients with rheumatoid arthritis to be at higher risk of postoperative cardiovascular morbidity and other morbidities linked to perioperative cardiovascular complications including infections. 13 However, closer inspection of the VASQIP database, which followed patients postprocedure for 3.7 ± 2.7 years, reveals that rheumatoid arthritis was associated with a significantly higher long-term mortality (hazard ratio, 1.22 [95% CI, 1.00-1.49]). These data again reinforce the importance of considering the consequences of noncardiac surgery beyond the time period over which administrative databases typically capture hospital morbidity. 14, 15 In addition, we cannot be sure that surgical and/or anesthesiology bias in preoperative patient screening apparently minimizes adverse perioperative outcomes by selecting out the patients with rheumatoid arthritis who have the most severe disease characterized by chronic multiorgan dysfunction. Only the presence, rather than severity, of rheumatoid arthritis was captured by the Cleveland Clinic study. In particular, multisystem organ dysfunction commonly found in rheumatoid disease including chronic kidney disease 16 is clearly associated with worse perioperative outcomes even in patients without rheumatoid arthritis. 17 Furthermore, the Cleveland Clinic study did not report on the risk of perioperative infectious complications. A retrospective longitudinal cohort study found substantial risk for objectively confirmed infections (adjusted hazard ratio, 1.70 [95% CI, 1.42-2.03]) and infections requiring hospitalization in patients with rheumatoid arthritis (adjusted hazard ratio, 1.83 [95% CI, 1.52-2.21]). Complications of musculoskeletal, skin, and respiratory infections were most prevalent. 18 The relative lack of data on the impact of medication for rheumatoid arthritis and perioperative outcomes is notable. The American College of Rheumatology guidelines recommend that rheumatoid arthritis patients stop taking biologic therapies 1 week before surgery and not restart them until a week after surgery. 19 However, the role of other diseasemodifying drugs remains unclear with generally retrospective or unblinded, low-quality studies providing limited information. 20 The systemic anti-inflammatory effect of disease modifying drugs may reduce cardiovascular morbidity over the longer term. 21 Two studies have associated preoperative cessation of biologic therapies with postoperative flare-ups of psoriasis 22 and rheumatoid arthritis. 23 Counterintuitively, continuing methotrexate may reduce the risk of postoperative infection and reduce flare-ups within 6 weeks of surgery. 23 Several of these drugs are now being considered for repurposing, 24 which may be of underappreciated benefit in noncardiac surgery. Translational experimental models also show that the immunosuppressive properties of chloroquine may decrease susceptibility to sepsis after hemorrhage. 25 The suggestion that longer-term, postdischarge outcomes are worse in patients with rheumatoid arthritis is of particular importance and concern, suggesting that the database approach can easily miss critical time windows. Furthermore, clinical comparisons need to be underpinned by a clear biologic rationale. Although rheumatoid arthritis is often compared with osteoarthritis, the biologic basis for this may be flawed. Laboratory models have established that osteoarthritis is a chronic inflammatory disease, sharing immunologic overlap with other diseases of autoimmunity. 26 Most strikingly, further subgroup analysis in the Cleveland Clinic study suggests that patients with rheumatoid arthritis and coexisting cardiovascular disease sustain more postoperative cardiovascular complications than control patients who do not have rheumatoid arthritis and coexisting cardiovascular disease. Our preoperative assessment of higher risk surgical patients by cardiopulmonary exercise testing shows that cardiopulmonary reserve is lower in 199 of 759 patients with arthritis ( Fig. 1) . Controlling for age-related decline in cardiopulmonary reserve, plus established cardiovascular pathology and diabetes mellitus, the anerobic threshold is 1.3 mL kg −1 min −1 lower (95% CI, 0.8-1.75; P = 0.015) in patients with arthritis (most frequently osteoarthritis). Given the association between low aerobic capacity (≤11 mL kg −1 min −1 ) and postoperative complications, 27 it is striking that patients with arthritis are more likely (relative risk, 1.68; 95% CI, 1.28-2.20; P < 0.0001) to demonstrate poorer cardiopulmonary reserve. These data suggest that the chronic proinflammatory process common to all arthritides may lead to a deconditioning phenotype and hence poorer cardiovascular performance under stress. Deconditioning may result from lower physical activity or accelerated cardiovascular disease leading to subclinical chronic cardiac failure.
These studies highlight the potential strengths and significant limitations of the large database approach. The apparent disconnect between the rheumatoid arthritis big data literature and established perioperative risk factors highlights 2 key contributions that perioperative medicine can make in a broader context. First, there is a clear need for a better understanding of how the progression of complex, multisystem diseases is altered by the perioperative phase and its management. Second, the unique translational potential of the perioperative arena not only offers an unrivalled opportunity to understand pathologic mechanisms and reduce postoperative complications but also provide other specialties' invaluable biological insights as to whether apparently paradoxical big data findings should shape their clinical practice. Mechanistic interrogation catalyzed by unexpected findings from observational and trial data sets have transformed many other areas of medicine, statin therapy for hypercholesteremia perhaps being the most notable. 28 Perioperative medicine requires a similar nonsiloed, complementary approach as bioinformatic analyses of large electronic databases generate plausible, although not necessarily conventional and/or predictable, Figure 1 . Association between arthritis and anerobic capacity. Unadjusted values shown for 199 of 759 patients with arthritis (osteoarthritis or rheumatoid) who underwent cardiopulmonary exercise testing at University College London Hospitals NHS Trust preoperative assessment for noncardiac surgery. Mean ± SD values are shown.
